Preference study with elderly patients recurrent ovarian cancer.
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Treosulfan (Primary) ; Treosulfan (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 27 Dec 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003949).
- 02 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Nov 2005 New trial record.